CSL to pump $1.5bn into US plasma supply chain
CSL will outlay $1.5bn over the next five years in the US to grow its footprint of plasma therapy production, the latest pharma company to pour money into the country amid tariff threats. Australia-headquartered CSL remained scant on details, though it said the planned investment will “generate hundreds of high-quality American jobs”. The US expansion … Read more